Role of cytokine p40 family in multiple sclerosis

Minerva Medica

Volumn 99, Issue 2, 2008, Pages 105-118

  Brahmachari, S ^a   Pahan, Kalipada ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Autoimmune diseases; Cytokines; Multiple sclerosis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 23; MESSENGER RNA; MONOMER; PROTEIN P40; PROTEIN SUBUNIT;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CYTOKINE PRODUCTION; DEMYELINATION; DOWN REGULATION; GLIOSIS; IMMUNE RESPONSE; INTERFERON PRODUCTION; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW;

ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME INDUCTION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-23; MULTIPLE SCLEROSIS; NITRIC OXIDE SYNTHASE TYPE II; T-LYMPHOCYTE SUBSETS;

EID: 46749156738     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Becher B, Durell BG, Noelle RJ. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J Clin Invest 2002;110:493-7.
2. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005;201:233-40.
3. Pahan K, Sheikh FG, Liu X, Hilger S, McKinney M, Petro TM. Induction of nitric-oxide synthase and activation of NF-kappaB by interleukin-12 p40 in microglial cells. J Biol Chem 2001;276:7899-905.
4. Gately MK, Renzetti LM, Magram J, Stern AS, Adorini L, Gubler U et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998;16:495-521.
5. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003;3:133-46.
6. Bacon CM, McVicar DW, Ortaldo JR, Rees RC, O'Shea JJ, Johnston JA. Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J Exp Med 1995;181:399-404.
7. Zou J, Presky DH, Wu CY, Gubler U. Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits beta1 and beta2 and JAK kinases. J Biol Chem 1997;272:6073-7.
8. Constantinescu CS, Goodman DB, Hilliard B, Wysocka M, Cohen JA. Murine macrophages stimulated with central and peripheral nervous system myelin or purified myelin proteins release inflammatory products. Neurosci Lett 2000;287:171-4.
9. Zipris D, Greiner DL, Malkani S, Whalen B, Mordes JP, Rossini AA. Cytokine gene expression in islets and thyroids of BB rats. IFN-gamma and IL-12p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats. J Immunol 1996;156:1315-21.
10. Ogawa M, Tsutsui T, Zou JP, Mu J, Wijesuriya R, Yu WG et al. Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites following administration of interleukin 12. Cancer Res 1997;57:2216-22.
11. Balabanov R, Strand K, Goswami R, McMahon E, Begolka W, Miller SD et al. Interferon-gamma-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis. J Neurosci 2007;27:2013-24.
12. Lin W, Bailey SL, Ho H, Harding HP, Ron D, Miller SD et al. The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. J Clin Invest 2007;117:448-56.
13. Wu C, Wang X, Gadina M, O'Shea JJ, Presky DH, Magram J. IL-12 receptor beta 2 (IL-12R beta 2)-deficient mice are defective in IL-12-mediated signaling despite the presence of high affinity IL-12 binding sites. J Immunol 2000;165:6221-8.
14. Watford WT, Hissong BD, Bream JH, Kanno Y, Muul L, O'Shea JJ. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 2004;202:139-56.
15. Morinobu A, Gadina M, Strober W, Visconti R, Fornace A, Montagna C et al. STAT4 serine phosphorylation is critical for IL-12-induced IFN-gamma production but not for cell proliferation. Proc Natl Acad Sci U S A 2002;99:12281-6.
16. Lu HT, Yang DD, Wysk M, Gatti E, Mellman I, Davis RJ et al. Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J 1999;18:1845-57.
17. Bö L, Dawson TM, Wesselingh S, Mörk S, Choi S, Kong PA et al. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 1994;36:778-86.
18. Liu JS, Zhao ML, Brosnan CF, Lee SC. Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol 2001;158:2057-66.
19. Taylor BS, de Vera ME, Ganster RW, Wang Q, Shapiro RA, Morris SM Jr et al. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J Biol Chem 1998;273:15148-56.
20. Saha RN, Pahan K. Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid Redox Signal 2006;8:929-47.
21. Saha RN, Pahan K. Signals for the induction of nitric oxide synthase in astrocytes. Neurochem Int 2006;49:154-63.
22. Xie QW, Whisnant R, Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med 1993;177:1779-84.
23. Martin E, Nathan C, Xie QW. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 1994;180:977-84.
24. Fujimura M, Tominaga T, Kato I, Takasawa S, Kawase M, Taniguchi T, Okamoto H, Yoshimoto T. Attenuation of nitric oxide synthase induction in IRF-1-deficient glial cells. Brain Res 1997;759:247-50.
25. Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L et al. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 1996;156:5-7.
26. Willenborg DO, Fordham S, Bernard CC, Cowden WB, Ramshaw IA. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 1996;157:3223-7.
27. Zhang GX, Gran B, Yu S, Li J, Siglienti I, Chen X et al. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J Immunol 2003;170:2153-60.
28. Tarrant TK, Silver PB, Wahlsten JL, Rizzo LV, Chan CC, Wiggert B et al. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J Exp Med 1999;189:219-30.
29. O'Sullivan A, Chang HC, Yu Q, Kaplan MH. STAT4 is required for interleukin-12-induced chromatin remodeling of the CD25 locus. J Biol Chem 2004;279:7339-45.
30. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 1992;176:1387-98.
31. Heinzel FP, Hujer AM, Ahmed FN, Rerko RM. In vivo production and function of IL-12 p40 homodimers. J Immunol 1997;158:4381-8.
32. van Boxel-Dezaire AH, Hoff SC, van Oosten BW, Verweij CL, Dräger AM, Adèr HJ et al. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann Neurol 1999;45:695-703.
33. Podlaski FJ, Nanduri VB, Hulmes JD, Pan YC, Levin W, Danho W et al. Molecular characterization of interleukin 12. Arch Biochem Biophys 1992;294:230-7.
34. Wang X, Wilkinson VL, Podlaski FJ, Wu C, Stern AS, Presky DH et al. Characterization of mouse interleukin-12 p40 homodimer binding to the interleukin-12 receptor subunits. Eur J Immunol 1999;29:2007-13.
35. Constantinescu CS, Goodman DB, Hilliard B, Wysocka M, Cohen JA. Murine macrophages stimulated with central and peripheral nervous system myelin or purified myelin proteins release inflammatory products. Neurosci Lett 2000;287:171-4.
36. Fassbender K, Ragoschke A, Rossol S, Schwartz A, Mielke O, Paulig A et al. Increased release of interleukin-12p40 in MS: association with intracerebral inflammation. Neurology 1998;51:753-8.
37. González-Scarano F, Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 1999;22:219-40.
38. Wiendl H, Hohlfeld R. Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials. Biodrugs 2002;16:183-200.
39. Sharief MK, Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med 1991;325:467-72.
40. Bonetti B, Raine CS. Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann Neurol 1997;42:74-84.
41. D'Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB et al. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 1996;184:2361-70.
42. Raine CS. Multiple sclerosis: TNF revisited, with promise. Nat Med 1995;1:211-4.
43. Becher B, Dodelet V, Fedorowicz V, Antel JP. Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J Clin Invest 1996;98:1539-43.
44. Jana M, Dasgupta S, Saha RN, Liu X, Pahan K. Induction of tumor necrosis factor-alpha (TNF-alpha) by interleukin-12 p40 monomer and homodimer in microglia and macrophages. J Neurochem 2003;86:519-28.
45. Huan J, Culbertson N, Spencer L, Bartholomew R, Burrows GG, Chou YK et al. Decreased FOXP3 levels in multiple sclerosis patients. J Neurosci Res 2005;81:45-52.
46. Ling EA, Wong WC. The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia 1993;7:9-18.
47. Roy A, Fung YK, Liu X, Pahan K. Up-regulation of microglial CD11b expression by nitric oxide. J Biol Chem 2006;281:14971-80.
48. Eng LF, Ghirnikar RS. GFAP and astrogliosis. Brain Pathol 1994;4:229-37.
49. Dasgupta S, Zhou Y, Jana M, Banik NL, Pahan K. Sodium phenylacetate inhibits adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice at multiple steps. J Immunol 2003;170:3874-82.
50. Brahmachari S, Fung YK, Pahan K. Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J Neurosci 2006;26:4930-9.
51. Parkinson JF, Mitrovic B, Merrill JE. The role of nitric oxide in multiple sclerosis. J Mol Med 1997;75:174-86.
52. Bizzozero OA, DeJesus G, Howard TA. Exposure of rat optic nerves to nitric oxide causes protein S-nitrosation and myelin decompaction. Neurochem Res 2004;29:1675-85.
53. Koprowski H, Spitsin SV, Hooper DC. Prospects for the treatment of multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitrite. Ann Neurol 2001;49:139.
54. Bossy-Wetzel E, Talantova MV, Lee WD, Schölzke MN, Harrop A, Mathews E et al. Crosstalk between nitric oxide arid zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels. Neuron 2004;41:351-65.
55. McDonald JW, Althomsons SP, Hyrc KL, Choi DW, Goldberg MP. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 1998;4:291-7.
56. Pitt D, Werner P, Raine CS. Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 2000;6:67-70.
57. Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000;13:715-25.
58. Parham C, Chirica M, Timans J, Vaisberg E, Travis M, Cheung J et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 2002;168:5699-708.
59. Trinchieri G, Pflanz S, Kastelein RA. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003;19:641-1.
60. Bettelli E, Oukka M, Kuchroo VK. T(H)-17cells in the circle of immunity and autoimmunity. Nat Immunol 2007;8:345-50.
61. Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B et al. Interleukin-23 rather than interleukin 12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003;421:744-8.
62. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney-AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003;278:1910-4.
63. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006;126:1121-33.
64. Stockinger B, Veldhoen M, Martin B. Th17 T cells: Linking innate and adaptive immunity. Semin Immunol